(Q77995505)

English

Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238

scientific article published on 01 August 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404076%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404076%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404076%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

Z Kahán

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404076%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

A Nagy

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404076%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

F Hebert

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404076%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

B Sun

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404076%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

K Groot

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404076%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

G Halmos

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404076%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

0 references

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404076%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404076%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

82

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404076%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404076%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

592-598

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404076%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

Analysis of somatostatin receptor subtype mRNA expression in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

Growth inhibition of human ovarian cancers by cytotoxic analogues of luteinizing hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

Internalization and subcellular distribution of radiolabeled somatostatin-28 in mouse anterior pituitary tumor cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

Mechanisms of antineoplastic action of somatostatin analogs

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

A cross-linking assay allows the detection of receptors for the somatostatin analogue, lanreotide in human breast tumours

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

Evaluation of receptors for somatostatin in various tumors using different analogs

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

Growth inhibition of estrogen independent MXT mouse mammary carcinomas in mice treated with an agonist or antagonist of LH-RH, an analog of somatostatin, or a combination

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

Somatostatin analogs for diagnosis and treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990812%2982%3A4%3C592%3A%3AAID-IJC20%3E3.0.CO%3B2-0

21 January 2018

Internalisation of isotope-coupled somatostatin analogues

0 references

Somatostatin receptor manipulation

0 references

Somatostatin receptor subtypes sst1, sst2, sst3 and sst5expression in human pituitary, gastroentero-pancreatic and mammary tumors

0 references

Identifiers

10.1002/(SICI)1097-0215(19990812)82:4<592::AID-IJC20>3.0.CO;2-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404076%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404076%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77995505&oldid=2239651678"